Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms | British Journal of Cancer
JCM | Free Full-Text | Implications of Hereditary Origin on the Immune Phenotype of Mismatch Repair-Deficient Cancers: Systematic Literature Review | HTML
Microsatellite Instability - Defective DNA Mismatch Repair
Internaliontil guidelines for evaluation of MSI in colorectal cancer | Download Table
Both MSI and IHC -
Distribution of microsatellite instability (MSI) status across cancer... | Download Scientific Diagram
The Landscape of Microsatellite Instability in Colorectal and Endometrial Cancer Genomes: Cell
Development of an MSI-positive colon tumor with aberrant DNA methylation in a PPAP patient | Journal of Human Genetics
Study Reinforces Treatment Idea for MSI-High Cancer - National Cancer Institute
MSI-H Biomarker | Colorectal Cancer Alliance
Microsatellite Instability as a Biomarker for PD-1 Blockade | Clinical Cancer Research
A. Multi-region sequencing data for a MSI-high colorectal cancer from... | Download Scientific Diagram
CCIs in colon cancer with MSS and MSI. The directions and number of... | Download Scientific Diagram
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer | NEJM
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability - ScienceDirect
Stomach and colorectal cancer: AI identifyies patients for immunotherapy • healthcare-in-europe.com
MSI as a predictive factor for treatment outcome of gastroesophageal adenocarcinoma - Cancer Treatment Reviews
Microsatellite instability in Gastric Cancer: Between lights and shadows - Cancer Treatment Reviews
Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancers | SpringerLink
The Landscape of Microsatellite Instability in Colorectal and Endometrial Cancer Genomes: Cell
Characterization and clinical evaluation of microsatellite instability and loss of heterozygosity in tumor‑related genes in gastric cancer
Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial† - Annals of Oncology
Assessment of the Circulating Tumor Cells and Microsatellite | OTT
Presence of MSI-H, MMR-D Predicts Lynch Syndrome Across Tumor Types
Immunotherapy Combination Approved for Colorectal Cancer - National Cancer Institute